Time-Resolved Fluorescent Immunochromatographic Test Strip for Paclitaxel Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for monitoring paclitaxel drug concentrations in clinical settings are inadequate due to low sensitivity, high cost, and lack of suitable detection reagents, making it difficult to manage efficacy and adverse reactions effectively.
Innovation Solution
A time-resolved fluorescent immunochromatographic test strip is developed, comprising a test paper with a fluorescent microsphere pad labeled with anti-paclitaxel monoclonal antibodies and a sample diluent, allowing for high sensitivity and specificity in paclitaxel detection with low production costs and simple use.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If Turbidimetric Inhibition Immunoassay (TIA) is used for PTX determination, then detection capability is provided, but sensitivity is low and cost is high
Solution Approach 1:
The patent replaces the traditional turbidimetric detection system with a fluorescent detection system using time-resolved fluorescent microspheres. This substitution of detection mechanism (from turbidimetric to fluorescent) enables significantly higher sensitivity while reducing reagent costs and improving overall cost-effectiveness for PTX determination
Solution Approach 2:
The patent changes the detection parameter from turbidimetry to time-resolved fluorescence. By using fluorescent microspheres with specific emission wavelengths and lifetimes, the system achieves enhanced sensitivity and specificity for PTX detection, resolving the contradiction between sensitivity and cost-effectiveness
2Measurement precision
If conventional detection methods (TLC, CE, HPLC) are used, then detection capability is provided, but they are not suitable for large-scale clinical promotion
Solution Approach 1:
The patent segments the complex HPLC/CE/TLC detection process into a simplified immunochromatographic format with discrete functional zones (detection line, control line, sample application area). This segmentation enables parallel processing of multiple samples and simplifies operation, making the system suitable for large-scale clinical promotion while maintaining detection capability
Solution Approach 2:
The test strip incorporates all necessary reagents (antibodies, fluorescent microspheres, buffer solutions) directly into the strip structure. The system performs self-contained detection without requiring external complex instrumentation or skilled operators, enabling easy scalability to clinical settings
3Reliability
If PTX monitoring is not performed, then treatment simplicity is maintained, but efficacy and adverse reactions cannot be effectively managed
Solution Approach 1:
The patent replaces complex laboratory-based monitoring systems with a simple fluorescent-based immunochromatographic test strip. The time-resolved fluorescent detection provides reliable PTX concentration measurements while maintaining operational simplicity through straightforward sample application and reading procedures
Solution Approach 2:
The patent changes the monitoring approach from complex multi-step analytical procedures to a single-step fluorescent intensity measurement. By measuring fluorescent signal intensity and comparing it to standards, the system achieves reliable treatment management capability while preserving ease of operation in clinical settings
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The test strip provides rapid, accurate, and cost-effective detection of paclitaxel with high specificity, capable of analyzing paclitaxel concentrations in clinical samples, improving monitoring and management of the drug's efficacy and adverse reactions.
Implementation Method 1
time-resolved fluorescent immunochromatographic test strip
Implementation Method 2
fluorescent microsphere-labeled anti-paclitaxel monoclonal antibody
Implementation Method 3
test paper including a bottom plate and a sample absorption pad
Implementation Method 4
sample diluent
Data Source
AI summary
Some embodiments of the disclosure provide a time-resolved fluorescent immunochromatographic test strip for detecting paclitaxel drugs as well as a preparation method and application thereof. In some embodiments, the test strip includes a test paper and a sample diluent. The test paper includes a bottom plate, a sample absorption pad, a fluorescent microsphere pad, a bonding pad, and an absorbent pad. The sample absorption pad, the fluorescent microsphere pad, the bonding pad, and the absorbent pad are sequentially overlapped on the bottom plate. The fluorescent microsphere pad is sprayed with a fluorescent microsphere-labeled anti-paclitaxel monoclonal antibody. A detection area and a quality control area are immobilized on the bonding pad. The detection area is sprayed with a paclitaxel hapten-carrier protein conjugate. The quality control area is sprayed with a goat anti mouse antibody.